U.S. Court of Appeals for the Federal Circuit, 2023

Takeda Pharmaceutical Company Limited v. Norwich Pharmaceuticals Inc.

Takeda Pharmaceutical Company Limited v. Norwich Pharmaceuticals Inc.
U.S. Court of Appeals for the Federal Circuit · Decided May 4, 2023

Takeda Pharmaceutical Company Limited v. Norwich Pharmaceuticals Inc.

Opinion

Case: 23-1374 Document: 37 Page: 1 Filed: 05/04/2023

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS U.S.A., INC., Plaintiffs-Appellees v. NORWICH PHARMACEUTICALS INC., Defendant-Appellant ______________________ 2023-1374 ______________________ Appeal from the United States District Court for the District of New Jersey in No. 2:20-cv-08966-SRC-CLW, Judge Stanley R. Chesler. ______________________ JUDGMENT ______________________ EDGAR HAUG, Haug Partners LLP, New York, NY, ar- gued for plaintiffs-appellees. Also represented by KAITLIN FARRELL, PORTER F. FLEMING, SHEILA MORTAZAVI, ANDREW SCOTT ROPER.

CHAD A. LANDMON, Axinn, Veltrop & Harkrider LLP, Hartford, CT, argued for defendant-appellant. Also repre- sented by THOMAS K. HEDEMANN, EDWARD M. MATHIAS, Case: 23-1374 Document: 37 Page: 2 Filed: 05/04/2023

FRANCIS H. MORRISON, III; JASON MURATA, San Francisco, CA. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (MOORE, Chief Judge, MAYER and HUGHES, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

May 4, 2023 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Case-law data current through December 31, 2025. Source: CourtListener bulk data.